MANAGEMENT OF DISSEMINATED DISEASE IN THE PATIENT WITH BLADDER-CANCER

Authors
Citation
Jj. Perry et Hb. Muss, MANAGEMENT OF DISSEMINATED DISEASE IN THE PATIENT WITH BLADDER-CANCER, Urologic clinics of North America, 21(4), 1994, pp. 661-672
Citations number
101
Categorie Soggetti
Urology & Nephrology
ISSN journal
00940143
Volume
21
Issue
4
Year of publication
1994
Pages
661 - 672
Database
ISI
SICI code
0094-0143(1994)21:4<661:MODDIT>2.0.ZU;2-P
Abstract
Advanced transitional cell carcinoma of the bladder is a chemotherapy- sensitive neoplasm. Several single agents demonstrate substantial acti vity, and combination chemotherapy produces responses in the majority of patients treated. The benefits and toxicities associated with the m ost widely used combination regimens are discussed. Other topics revie wed include the use of colony-stimulating factor support for chemother apy, adjunctive surgical therapy, and newer cytotoxic regimens.